“…Thus, strategies for surpassing this typically involves using an excess amount of amine donors (such as l ‐alanine or isopropylamine) and/or coupled reactions to remove the co‐product or to recycle the amine donor (Wu et al ., 2016 ; Wu et al ., 2017a ; Zhou et al ., 2018 ). Whole‐cell transamination (Weber et al ., 2014a ; Weber et al ., 2017 ; Patil et al ., 2019 ; Molnár et al ., 2019 ) offers several advantages over in vitro because it supplies PLP and amine donor, recycles cofactors, removes co‐product, as well as simplifies upstream preparation of the biocatalyst, which altogether result in significant process improvement (Tufvesson, Lima‐Ramos, Jensen, et al ., 2011 ; Tufvesson, Lima‐Ramos, Nordblad, et al ., 2011 ). On the other hand, whole‐cell systems are often sensitive to adverse process conditions, such as high titres of inhibitory substrates and products.…”